Clinical Trial Details
EORTC-62883
Back to Clinical Trials Database
Phase II clinical study of the use of granulocyte-macrophage colony-stimulating factor (GM-CSF) with chemotherapy (adriamycin andifosfamide) in the treatment of advanced soft tissue sarcomas in adults
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 01-Jul-1989 Date Step1 close: 01-Jun-1990 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 20 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |